Company Filing History:
1 out of 7 
1 out of 267 
1 out of 1 Years Active: 2016
Title: Gregory Goodall: Innovator in Therapeutic and Diagnostic Molecules
Introduction
Gregory Goodall is a notable inventor based in Netherby, Australia. He has made significant contributions to the field of therapeutic and diagnostic molecules, particularly in the modulation of angiogenesis. His innovative work has implications for various medical conditions associated with abnormal blood vessel formation.
Latest Patents
Goodall holds a patent for his invention titled "Therapeutic and diagnostic molecules." This patent relates to methods for modulating angiogenesis by administering specific miRNA or their antagonists. The invention includes methods for diagnosing conditions linked to abnormal angiogenesis and determining predisposition to such conditions. His patent is a valuable addition to the field, providing new avenues for treatment and diagnosis.
Career Highlights
Throughout his career, Gregory Goodall has worked with esteemed organizations such as the Centenary Institute of Cancer Medicine and Cell Biology and the University of Sydney Commercial Development & Industry Partnerships. His experience in these institutions has allowed him to advance his research and contribute to significant scientific advancements.
Collaborations
Goodall has collaborated with notable colleagues, including Jennifer Gamble and Mathew Vadas. These partnerships have fostered a collaborative environment that enhances research and innovation in the field of therapeutic molecules.
Conclusion
Gregory Goodall's contributions to the field of therapeutic and diagnostic molecules highlight his role as an influential inventor. His work continues to impact medical research and treatment options for conditions related to angiogenesis.